Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay, Natera Seeks Full Remedies As Case Enters New Phase
Portfolio Pulse from Benzinga Newsdesk
A court has issued a permanent injunction against NeoGenomics' RaDaR assay, favoring Natera in a legal dispute. Natera is now seeking full remedies as the case progresses.
September 23, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Natera has won a legal battle with a court issuing a permanent injunction against NeoGenomics' RaDaR assay. Natera is pursuing full remedies, which could strengthen its market position.
The court's decision in favor of Natera and the pursuit of full remedies could enhance Natera's competitive edge and market share, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80